Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H29N.ClH |
| Molecular Weight | 331.923 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)N(CCC(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C
InChI
InChIKey=ZYMHFUWAJIWDKD-UHFFFAOYSA-N
InChI=1S/C21H29N.ClH/c1-17(2)22(18(3)4)16-15-21(19-11-7-5-8-12-19)20-13-9-6-10-14-20;/h5-14,17-18,21H,15-16H2,1-4H3;1H
| Molecular Formula | C21H29N |
| Molecular Weight | 295.4617 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Diisopromine, a spasmolytic and a choleretic, in combination with sorbitol was marketed under the brand name Agofell. Agofell is prescribed for the biliary stasis and biliary insufficiency, hypotonia of the gall bladder, spasm of the biliary duct and of the sphincter of Oddi, cholecystitis, cholelithiasis, post cholecystotomy syndrome.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:38 GMT 2025
by
admin
on
Mon Mar 31 18:02:38 GMT 2025
|
| Record UNII |
9E8EN393AL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m694
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL2110849
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
SUB01730MIG
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
71910
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
C65388
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
9E8EN393AL
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
24358-65-4
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
100000087489
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
246-201-9
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY | |||
|
DTXSID70947216
Created by
admin on Mon Mar 31 18:02:38 GMT 2025 , Edited by admin on Mon Mar 31 18:02:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |